and Li et al
Gut 70 , 16651674 (2021)
Our medical team uses a "lowest effective dose" model: We start every member at the lowest clinically appropriate dose We only escalate if progress stalls and all behavioral strategies have been exhausted We monitor for side effects continuously and reduce doses when appropriate A 2021 study in JAMA found that most patients regain lost weight within 12 months of stopping GLP-1s without behavioral support
As a GLP-1 receptor agonist, semaglutide works by helping regulate blood glucose levels, slowing gastric emptying, and mimicking a hormone that helps reduce appetite
Our core IV menu includes hydration, energy, immunity, performance and recovery, and beauty formulations, along with NAD+ and high-dose vitamin C
But for something so easy to overlook, so simple to test, and so straightforward to fix, it's remarkable how much of a difference correcting a deficiency can make